ANNA WILHOIT: Open Payments
NPI 1104366285 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,186 in 92 payments from 15 companies in 2025. Trend: 2023 $1,108 · 2024 $1,325 · 2025 $2,186
Food & beverage: $2,186
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 21 | $492 |
| Otsuka America Pharmaceutical, Inc. | 14 | $421 |
| E.R. Squibb & Sons, L.L.C. | 10 | $270 |
| Janssen Pharmaceuticals, Inc | 5 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $184 |
| ABBVIE INC. | 13 | $143 |
| Biogen, Inc. | 6 | $123 |
| Lundbeck LLC | 6 | $96 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Almatica Pharma LLC | 2 | $46 |
Products named: REXULTI, HETLIOZ, COBENFY, SPRAVATO, FANAPT, CAPLYTA, VRAYLAR, ZURZUVAE.
Industry payments across KY — which companies pay providers there.
